title: The safety of nitrofurantoin for the treatment of nosocomial catheter-associated bacteriuria (CAB) and cystitis.
authors.forename: Burke A
authors.initials: BA
authors.lastname: Cunha
authors.forename: Philip
authors.initials: P
authors.lastname: Lee
authors.forename: Nicole
authors.initials: N
authors.lastname: Kaouris
authors.forename: Muhammad
authors.initials: M
authors.lastname: Raza
mesh_terms: D000284:Administration, Oral; D016907:Adverse Drug Reaction Reporting Systems; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001437:Bacteriuria / Q000188:drug therapy* / Q000382:microbiology / Q000652:urine; D055499:Catheter-Related Infections / Q000188:drug therapy* / Q000382:microbiology / Q000652:urine; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology / Q000652:urine; D003556:Cystitis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology / Q000652:urine; D006784:Hospitals, Teaching; D006801:Humans; D009518:New York; D009582:Nitrofurantoin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001743:Urinary Bladder / Q000187:drug effects / Q000382:microbiology; D014546:Urinary Catheterization / Q000009:adverse effects
chemical_list: D000892:Anti-Infective Agents, Urinary; D009582:Nitrofurantoin